Please enable Javascript to use all features and improve your user experience.
EHC 2023
Programme
People
Search
DE
Back
ePoster
P029
Benefit-Risk assessment based on number needed to treat and number needed to harm: Atogepant vs. calcitonin gene–related peptide monoclonal antibodies
Simona Sacco
L'Aquila AQ, IT
Appointment
Date:
06/12/2023
Time:
20:15
–
20:20
Talk time:
3 Min.
Discussion time:
2 Min.
Location / Stream:
Headache theatre
Poster
Benefit-Risk assessment based on number needed to treat and number needed to harm: Atogepant vs. calcitonin gene–related peptide monoclonal antibodies
Session
ePoster 02
Topic
New developments in prophylactic medications and acute medications
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy